Stefanie Kammerman, the Stock Whisperer, to tell you the Whisper of the Week: GLD and SLV in my week...
Cummins Firing on All Cylinders
04/27/2011 4:00 pm EST
Considering all the headwinds, shares of Companhia de Bebidas das Americas—better known as AmBev (ABV)—have done just fine this year.
The headwinds include:
- Rising prices for the raw materials that go into the company’s beer.
- And rumors that a big international competitor, such as SABMiller, will buy Brazil’s second largest brewer, Primo Schincaril Industria de Cervejas e Refrigerantes, and put big money into taking some of AmBev's 70% market share in Brazil.
- And, the biggest headwind of all, fears that the government of Brazilian President Dilma Rousseff is losing the fight against inflation.
That last fear has pushed Brazil’s Bovespa down 5.2% this year.
In contrast, shares of AmBev are up 4.96% for the year. As I said, considering the headwinds, just fine.
Part of that outperformance comes from AmBev’s strong moves to fix a cost problem that popped up in the middle of 2010. Raw materials prices had climbed so fast that the company hadn’t raised prices fast enough to keep pace.
The company bit the bullet in the fourth quarter of 2010 (as reported March 3), and raised prices by 9%. That did, as I’m sure the company had feared, cut volume growth from 8.5% in the fourth quarter of 2009.
But volume growth still came in positive for the quarter, at 2.7%. Combine that with the price increase, and revenue climbed 12% from the fourth quarter of 2009. The company’s profit margin increased by 3.1 percentage points.
With that problem fixed, I think investors can focus on how strong they think the headwinds will blow for the rest of 2011. (And you’ll need to add another headwind: A change in the tax for beer, water, and soft drinks in Brazil that will increase AmBev’s tax by about 15% this year. Recouping that increase would require another 1.5% price increase.)
I think worries about inflation in Brazil will limit gains for all Brazilian stocks until the government and central bank can demonstrate that their policies are working. (For more on Brazil’s turn for the worse on inflation policy see my post.)
I think that will take a good three to six months—at least. In that period I’d be looking to build positions in Brazilian stocks for 2012, but I certainly wouldn’t be looking to get outperformance from the Bovespa.
From that point of view, I don’t think the question is whether AmBev deserves a place in your portfolio—I think the biggest brewer in Latin America is a key holding to profit from rising incomes in the continent’s economies—but what place it deserves.
I think you’ll be quite happy with the stock over the next six to 12 months if you think of it, and give it a slot in your portfolio, as a total return or dividend-income stock.
The shares are likely to pay a projected dividend yield of 5.8% this year, according to Morningstar. (Why a projected yield? A good piece of the dividend is in the form of a special dividend that varies with the company’s profits.)
On the other hand, if you slot this in your portfolio as a growth stock, I think you’re likely to be disappointed with AmBev in 2011. So I’m going to make a switch and move AmBev from my Jubak’s Picks portfolio to my Dividend Income portfolio.
The software on the JubakPicks.com site isn’t really set up for this kind of switch, so I’m going to have to do it in two parts. Today, April 29, I’m selling AmBev out of the Picks portfolio with a gain of 56.6% since I added it to that list on January 13, 2010.
On Monday—assuming markets aren’t nuts—I’ll add it to the dividend portfolio. Watch for the buy.
Full disclosure: I don’t own shares of any of the companies mentioned in this column in my personal portfolio. The mutual fund I manage, Jubak Global Equity Fund (JUBAX), may or may not now own positions in any stock mentioned in this column. The fund did not own shares of AmBev as of the end of March. For a full list of the stocks in the fund as of the end of March, see the fund’s portfolio here.
Related Articles on STOCKS
As the world faces an increasing onslaught of new threats from biological and chemical weapons, viru...
Hologic (HOLX), a leading provider of mammography equipment and diagnostic services for obstetrician...
International Game Technology PLC (IGT) designs, manufactures, and markets electronic gaming equipme...